Wedbush Securities Inc Insulet Corp Transaction History

Wedbush Securities Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$192.55 - $236.59 $237,029 - $291,242	-1,231 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$159.17 - $224.73 $3,024 - $4,269	-19 Reduced 1.52%	1,231 $239,000
Q1 2020 Apr 17, 2020	BUY	$130.01 - $216.44 $1,560 - $2,597	12 Added 0.97%	1,250 $207,000
Q4 2019 Jan 16, 2020	SELL	$144.81 - $186.0 $2,606 - $3,348	-18 Reduced 1.43%	1,238 $212,000
Q3 2019 Oct 17, 2019	BUY	$117.35 - $167.95 $147,391 - $210,945	1,256 New	1,256 $207,000

743

63.9M

628K

854K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.